Stem Cell Secretome Treatment Reduces Adiposity and Improves Glucose Handling During Obesity and Weight Loss in Mice
Obesity · 2026
DOI: 10.1002/oby.70068 ↗At a glance
Journal article in Obesity, 2026. Written by Zachary J Fennel and 11 co-authors. Institution: Diabetes & Metabolism Research Center, University of Utah, Salt Lake City, Utah, USA. Major MEDLINE topics: Weight Loss, Obesity, Adiposity, Secretome. 40 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIA NIH HHS, NIDDK NIH HHS, Immunis Inc..
Abstract (original language)
Objective
In this study, we investigated the effects of a stem cell‐derived secretome product on adiposity and tissue quality and insulin and glucose levels in obese mice and those undergoing dietary weight loss.
Methods
Following 16 weeks of high fat diet mice received acute (4 weeks) biweekly intramuscular injections with vehicle or secretome while remaining on a high fat diet (HFD vs. HFD‐S) or during weight loss upon return to a normal chow diet (HFD/WL vs. HFD/WL‐S).
Results
After 4 weeks of treatment, HFD‐S mice had greater lean mass (vs HFD), muscle weights, and quadriceps myofibrillar size and improved muscle quality (capillary density and fibrosis). HFD/WL‐S mice had accelerated whole‐body fat loss and improved glucose handling, fasting insulin levels, and HOMA‐IR. In both secretome‐treated groups (HFD‐S and HFD/WL‐S), liver steatosis and fibrosis were improved and similar to chow controls.
Conclusions
Together, these results support that a stem cell secretome treatment may be useful to improve tissue quality and metabolic health during obesity and weight loss.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Diabetes & Metabolism Research Center, University of Utah, Salt Lake City, Utah, USA.
- Department of Physical Therapy and Athletic Training, University of Utah, Salt Lake City, Utah, USA.
- Molecular Medicine Program, University of Utah, Salt Lake City, Utah, USA.
- Department of Nutrition & Integrative Physiology, University of Utah, Salt Lake City, Utah, USA.
- Immunis, Inc., Irvine, California, USA.
- Department of Neurobiology and Behavior, University of California, Irvine, California, USA.
ORCID profiles: Zachary J Fennel, Robert J Castro, Micah J Drummond
Funding
- NIA NIH HHS
- NIDDK NIH HHS
- Immunis Inc.
- National Institute of Diabetes and Digestive and Kidney Diseases
Cite
APA
Fennel, Z. J., Kurian, A. S., Bourrant, P. E., Skiles, C. M., Castro, R. J., Yee, E. M., Greilach, S. A., Keirstead, H. S., Nistor, G., Berchtold, N. C., Lane, T. E., & Drummond, M. J. (2026). Stem Cell Secretome Treatment Reduces Adiposity and Improves Glucose Handling During Obesity and Weight Loss in Mice. Obesity. https://doi.org/10.1002/oby.70068
Vancouver
Fennel ZJ, Kurian AS, Bourrant PE, Skiles CM, Castro RJ, Yee EM, et al. Stem Cell Secretome Treatment Reduces Adiposity and Improves Glucose Handling During Obesity and Weight Loss in Mice. Obesity. 2026. doi:10.1002/oby.70068
BibTeX
@article{Fennel2026,
author = {Fennel, Zachary J and Kurian, Anu S and Bourrant, Paul-Emile and Skiles, Chad M and Castro, Robert J and Yee, Elena M and Greilach, Scott A and Keirstead, Hans S and Nistor, Gabriel and Berchtold, Nicole C and Lane, Thomas E and Drummond, Micah J},
title = {Stem Cell Secretome Treatment Reduces Adiposity and Improves Glucose Handling During Obesity and Weight Loss in Mice},
journal = {Obesity},
year = {2026},
doi = {10.1002/oby.70068}
}
EUVIMED